Skip to main content

Table 6 Mean (M) and standard deviation (SD) of secondary outcome variables in 1011 migraine patients at baseline and after 3 months under preventive treatment (demographic data are reported in Table 1)

From: Failure of preventive treatments in migraine: an observational retrospective study in a tertiary headache center

Condition

MIDAS

VAS

ALLODYNIA

PH SF36

MH SF36

Baseline

M

33.30

8.82

2.81

36.59

38.67

SD

43.97

1.16

2.00

8.93

8.75

Follow-up

M

21.74

8.30

2.40

38.10

39.48

SD

31.22

1.46

1.98

8.74

8.99

Within-subject ANOVA

F

2.93

9.39

3.39

1.14

1.37

DF

2

2

2

2

2

P

0.053

< 0.001

0.034

0.31

0.25

  1. MANOVA, condition (baseline vs follow-up): F (Roy square) = 5.12, DF = 5, p < 0.0001; condition vs drug: F = 0.64, DF = 5, P = 0.69; condition vs migraine type: F = 1.83, DF = 5 p = 0.1; condition vs drug vs migraine type: F = 0.55, DF = 12, p = 0.88. The within-subject ANOVA results are reported
  2. PH physical Health score SF36, MH mental health score SF36